搜索临床试验以:CP-4126
总计2021个结果
-
Ultragenyx Pharmaceutical Inc完全的长链脂肪酸氧化障碍 (LC-FAOD) | 极长链酰基辅酶 A 脱氢酶 (VLCAD) 缺乏症 | 三功能蛋白 (TFP) 缺乏症 | 肉碱棕榈酰转移酶 (CPT II) 缺乏症 | 长链 3-羟基酰基辅酶 A 脱氢酶 (LCHAD) 缺乏症美国, 英国
-
Abramson Cancer Center of the University of Pennsylvania完全的
-
Sichuan Baili Pharmaceutical Co., Ltd.SystImmune Inc.; Baili-Bio (Chengdu) Pharmaceutical Co., Ltd.招聘中
-
JenaValve Technology, Inc.终止
-
The Royal Wolverhampton Hospitals NHS Trust完全的
-
NYU Langone HealthAstraZeneca撤销
-
Virginia Commonwealth University完全的
-
Northwestern UniversityUniversity of Chicago; University of Illinois at Chicago; Shirley Ryan AbilityLab主动,不招人
-
Roswell Park Cancer InstituteAstraZeneca主动,不招人BRCA1基因突变 | BRCA2基因突变 | 复发性输卵管癌 | 复发性卵巢癌 | 复发性原发性腹膜癌 | 卵巢浆液性腺癌美国
-
University of WashingtonNational Cancer Institute (NCI); AstraZeneca终止
-
Pfizer完全的
-
University of GiessenStrathmann AG&Co, Hamburg, Germany; Cernelle, Ängelholm, Sweden完全的
-
Danish Research Centre for Magnetic ResonanceDepartment of Physical- and Occupational Therapy; Hvidovre Hospital; Department of Pediatrics... 和其他合作者尚未招聘
-
Delta University for Science and Technology招聘中
-
PolyNovo Biomaterials Pty Ltd.Biomedical Advanced Research and Development Authority招聘中
-
Bioness Inc招聘中
-
PolyNovo Biomaterials Pty Ltd.终止
-
Shockwave Medical, Inc.完全的
-
ReFlow Medical, Inc.完全的